MedTrace Logo

Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

NCT07091526 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2025-12-19

No results posted yet for this study

Summary

This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.

Conditions

  • Serum Uric Acid

Interventions

DIAGNOSTIC_TEST

serum uric acid test

Detect the serum uric acid in blood sample

Sponsors & Collaborators

  • Hepatopancreatobiliary Surgery Institute of Gansu Province

    lead OTHER

Principal Investigators

  • Wenbo Meng, M.D. Ph. D. · Hepatopancreatobiliary Surgery Institute of Gansu Province

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-29
Primary Completion
2026-12-29
Completion
2026-12-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07091526 on ClinicalTrials.gov